PGE2 Augments Inflammasome Activation and M1 Polarization in Macrophages Infected With Typhimurium and
Overview
Authors
Affiliations
Eicosanoids are cellular metabolites, which shape the immune response, including inflammatory processes in macrophages. The effects of these lipid mediators on inflammation and bacterial pathogenesis are not clearly understood. Certain eicosanoids are suspected to act as molecular sensors for the recruitment of neutrophils, while others regulate bacterial uptake. In this study, gene expression analyses indicated that genes involved in eicosanoid biosynthesis including COX-1, COX-2, DAGL, and PLA-2 are differentially regulated in THP-1 human macrophages infected with Typhimurium or . By using targeted metabolomics approach, we found that the eicosanoid precursor, arachidonic acid (AA) as well as its derivatives, including prostaglandins (PGs) PGF2α or PGE2/PGD2, and thromboxane TxB2, are rapidly secreted from macrophages infected with these Gram-negative pathogenic bacteria. The magnitude of eicosanoid biosynthesis in infected host cells depends on the presence of virulence factors of and Typhimurium strains, albeit in an opposite way in compared to Typhimurium infection. Trials with combinations of EP2/EP4 PGE2 receptor agonists and antagonists suggest that PGE2 signaling in these infection models works primarily through the EP4 receptor. Downstream of EP4 activation, PGE2 enhances inflammasome activation and represses M2 macrophage polarization while inducing key M1-type markers. PGE2 also led to a decreased numbers of within macrophages. To summarize, PGE2 is a potent autocrine/paracrine activator of inflammation during infection in Gram-negative bacteria, and it affects macrophage polarization, likely controlling bacterial clearance by macrophages.
Santelices J, Schultz A, Schultz A, Walker A, Adams N, Tirado D bioRxiv. 2025; .
PMID: 39975367 PMC: 11838268. DOI: 10.1101/2025.01.27.635188.
Taddeo J, Wilson N, Kowal A, Beld J, Andres K, Tukel C Gut Microbes. 2024; 16(1):2419567.
PMID: 39508622 PMC: 11545264. DOI: 10.1080/19490976.2024.2419567.
Das U Medicina (Kaunas). 2024; 60(6).
PMID: 38929553 PMC: 11205989. DOI: 10.3390/medicina60060934.
Crosstalk between efferocytic myeloid cells and T-cells and its relevance to atherosclerosis.
Ngai D, Sukka S, Tabas I Front Immunol. 2024; 15:1403150.
PMID: 38873597 PMC: 11169609. DOI: 10.3389/fimmu.2024.1403150.
Deng Q, Yang Y, Liu Y, Zou M, Huang G, Yang S Front Pharmacol. 2024; 15:1335836.
PMID: 38873410 PMC: 11169855. DOI: 10.3389/fphar.2024.1335836.